Ivabradine – a new agent for coronary heart disease treatment
The review is devoted to ivabradine – the first If selective and specific inhibitor, reducing heart rate (HR). It is well known that HR is an independent risk factor, increasing incidence of all-cause, sudden, and cardiovascular death. Ivabradine specifically and dose-dependently binds to f-channels...
Saved in:
Main Authors: | O. A. Maneshina, S. B. Erofeeva, Yu B. Belousov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1205 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine
by: Yu. B. Belousov, et al.
Published: (2007-12-01) -
IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01) -
Modern opportunities of heart rate regulation in coronary heart disease
by: N. Sh. Zagidullin, et al.
Published: (2013-10-01) -
IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01) -
ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01)